Nano-X Imaging Ltd. (NNOX)
NASDAQ:NNOX
Want to see NNOX full AI Analyst Report?
NNOX Stock Chart & Stats
$1.72
-$0.69(-7.28%)
At close: 4:00 PM EST
$1.72
-$0.69(-7.28%)
Day’s Range― - ―
52-Week Range$1.59 - $5.72
Previous CloseN/A
Volume2.46M
Average Volume (3M)1.94M
Market Cap
$128.05M
Enterprise Value$86.75M
Total Cash (Recent Filing)$59.61M
Total Debt (Recent Filing)$7.85M
Price to Earnings (P/E)―
Beta1.44
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares Outstanding69,590,225
10 Day Avg. Volume1,295,586
30 Day Avg. Volume1,942,805
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.30
Price to Sales (P/S)13.93
P/FCF Ratio-4.03
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue6.66
Enterprise Value/Gross Profit-6.78
Enterprise Value/Ebitda-1.77
Forecast
1Y Price Target
$6.00Price Target Upside248.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.53
Revenue Forecast (FY)$31.85M
Bulls Say, Bears Say
Bulls Say
Large Commercial Distribution Frameworks And PipelineMaterial channel agreements and a multi-hundred system pipeline create durable demand optionality versus one-off sales. Large frameworks can drive multi-year placement schedules, enabling recurring service revenue, scale for software/teleradiology, and potential unit-cost improvements as deployments expand.
Growing Recurring Teleradiology Revenue With Healthy MarginsHigh-margin teleradiology service revenue offers a structurally attractive recurring revenue base independent of hardware sales. Sustained growth and near-50% gross margins improve cash generation potential over time and help insulate the business from early-stage hardware unit economics.
Low Financial Leverage And Material Cash ResourcesA low debt load and reported cash (~$60M at year-end) provide runway to fund commercialization and restructuring efforts without heavy near-term refinancing. This balance sheet flexibility reduces solvency risk while management executes regulatory, deployment and product development plans.
Bears Say
Persistent Negative Gross Profit And Substantial Cash BurnSustained negative gross profit and large operating cash outflows indicate the core business is not yet cash-generative. Continued cash burn will require funding rounds or material margin improvement; until unit economics flip, equity is being eroded and long-term viability depends on execution.
Restructuring Led To Sizable Impairment And Execution RiskA significant impairment tied to moving manufacturing offshore highlights prior execution issues and adds uncertainty. While outsourcing may lower future OpEx, the restructuring caused asset write-downs, potential one-time cash costs and signals the company must reestablish reliable, cost-effective supply chains.
Negative Unit Economics On Early System DeploymentsEarly hardware deployments currently lose money, implying per-unit costs and installation economics are unfavorable at small scale. Durable profitability depends on improving manufacturing yields, reducing per-unit costs, and faster, predictable onboarding of pipeline systems to reverse these negative unit economics.
Nano-X Imaging News
NNOX FAQ
What was Nano-X Imaging Ltd.’s price range in the past 12 months?
Nano-X Imaging Ltd. lowest stock price was $1.59 and its highest was $5.72 in the past 12 months.
What is Nano-X Imaging Ltd.’s market cap?
Nano-X Imaging Ltd.’s market cap is $128.05M.
When is Nano-X Imaging Ltd.’s upcoming earnings report date?
Nano-X Imaging Ltd.’s upcoming earnings report date is May 27, 2026 which is today.
How were Nano-X Imaging Ltd.’s earnings last quarter?
Currently, no data Available
Is Nano-X Imaging Ltd. overvalued?
According to Wall Street analysts Nano-X Imaging Ltd.’s price is currently Undervalued.
Does Nano-X Imaging Ltd. pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
What is Nano-X Imaging Ltd.’s EPS estimate?
Nano-X Imaging Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nano-X Imaging Ltd. have?
Nano-X Imaging Ltd. has 69,590,225 shares outstanding.
What happened to Nano-X Imaging Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nano-X Imaging Ltd.?
Currently, no hedge funds are holding shares in NNOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nano-X Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (248.84% Upside)
$6.00 (248.84% Upside)
Blogger Sentiment
Bullish
NNOX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 320.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Very Bearish
Bullish news 19%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.40%
12-Months-Change
Fundamentals
Return on Equity
-47.09%
Trailing 12-Months
Asset Growth
-22.78%
Trailing 12-Months
Company Description
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
NNOX Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Balanced/Neutral — The call highlighted meaningful commercial progress: large distribution frameworks (including a 300-system Howard agreement), an expanded sales pipeline (~400 systems potential), regulatory advances, product awards, and an acquisition that immediately contributed revenue and IT capabilities. However, these operational and commercial positives are offset in the near term by significant financial headwinds: a large GAAP loss driven by a $17.5M impairment tied to a manufacturing restructuring, deteriorated non-GAAP gross margins (32% vs 9% prior), continued losses on early hardware deployments, and elevated operating expenses. Management expects a revenue inflection in the second half of 2026, but deployment timing and conversion of the pipeline into sustainable revenue remain key risks.View all NNOX earnings summariesNNOX Stock 12 Month Forecast
Average Price Target
$6.00
▲(248.84% Upside)
Technical Analysis
Ownership Overview
0.07% Insiders
2.44% Mutual Funds
6.12% Other Institutional Investors
85.15% Public Companies and
Individual Investors